Do patients with COPD benefit from treatment with inhaled corticosteroids?

Eur Respir J. 1996 Oct;9(10):1969-72. doi: 10.1183/09031936.96.09101969.
No abstract available

Publication types

  • Editorial
  • Meta-Analysis

MeSH terms

  • Administration, Inhalation
  • Adult
  • Anti-Inflammatory Agents / administration & dosage
  • Anti-Inflammatory Agents / therapeutic use*
  • Asthma / drug therapy
  • Asthma / physiopathology
  • Beclomethasone / administration & dosage
  • Beclomethasone / therapeutic use
  • Bronchial Hyperreactivity / drug therapy
  • Bronchial Hyperreactivity / physiopathology
  • Bronchodilator Agents / administration & dosage
  • Bronchodilator Agents / therapeutic use
  • Budesonide
  • Follow-Up Studies
  • Forced Expiratory Volume / drug effects
  • Forecasting
  • Glucocorticoids / administration & dosage
  • Glucocorticoids / therapeutic use*
  • Humans
  • Lung Diseases, Obstructive / drug therapy*
  • Lung Diseases, Obstructive / physiopathology
  • Peak Expiratory Flow Rate / drug effects
  • Pregnenediones / administration & dosage
  • Pregnenediones / therapeutic use
  • Randomized Controlled Trials as Topic
  • Smoking / physiopathology
  • Vital Capacity / drug effects

Substances

  • Anti-Inflammatory Agents
  • Bronchodilator Agents
  • Glucocorticoids
  • Pregnenediones
  • Budesonide
  • Beclomethasone